Start
Completion

Psilocybin Therapy for Chronic Low Back Pain

RecruitingRegisteredCTG

Randomized, quadruple-blind, parallel-group trial (n=30) testing single oral psilocybin doses (1–30 mg) combined with zolpidem, modafinil, both, or placebo for adults with chronic low back pain.

Details

This study evaluates whether psilocybin therapy helps patients cope with chronic low back pain more effectively. Procedures occur at UCSF; participants receive two preparation sessions, a single dosing session (6–8 hours), three integration sessions, and follow-up visits.

Four parallel arms compare single-dose psilocybin (1–30 mg, oral) combined with zolpidem and modafinil, zolpidem alone, modafinil alone, or placebo. Outcomes include pain-related distress, functioning, mood and safety.

Topics:Chronic Pain

Registry

Registry linkNCT05351541